Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies

Cugno, C., Deola, S., Filippini, P., Stroncek, D.F. and Rutella, S. ORCID: 0000-0003-1970-7375, 2015. Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies. Journal of Translational Medicine, 13, p. 362. ISSN 1479-5876

Preview

Text PubSub5942_Rutella.pdf - Published version Download (1MB) | Preview

Abstract

Bacterial and fungal infections continue to pose a major clinical challenge in patients with prolonged severe neutropenia after chemotherapy or hematopoietic stem cell transplantation (HSCT). With the advent of granulocyte colony-stimulating factor (G-CSF) to mobilize neutrophils in healthy donors, granulocyte transfusions have been broadly used to prevent and/or treat life-threatening infections in patients with severe febrile neutropenia and/or neutrophil dysfunction. Although the results of randomized controlled trials are inconclusive, there are suggestions from pilot and retrospective studies that granulocyte transfusions may benefit selected categories of patients. We will critically appraise the evidence related to the use of therapeutic granulocyte transfusions in children and adults, highlighting current controversies in the field and discussing complementary approaches to modulate phagocyte function in the host.

Item Type:	Journal article
Publication Title:	Journal of Translational Medicine
Creators:	Cugno, C., Deola, S., Filippini, P., Stroncek, D.F. and Rutella, S.
Publisher:	Biomed Central
Date:	November 2015
Volume:	13
ISSN:	1479-5876
Identifiers:	Number Type 10.1186/s12967-015-0724-5 DOI
Divisions:	Schools > School of Science and Technology
Record created by:	Linda Sullivan
Date Added:	08 Sep 2016 08:58
Last Modified:	09 Jun 2017 14:05
URI:	https://irep.ntu.ac.uk/id/eprint/28408

Actions (login required)

Edit View

Views

Downloads